GlassScriptPhysician profile
Jonathan Maksumov
NPI 1063877082
$532.29
in general payments reported to CMS, 2019-2025
8 companies · $392 in 2025
The $392 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $79.79 · 2024: $60.88 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intra-Sana Laboratories | $150.00 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Janssen Pharmaceuticals, INC | $132.70 | 2025 | Spravato |
| Amgen INC. | $60.88 | 2024 | Tepezza, Krystexxa |
| Indivior INC. | $55.11 | 2025 | Sublocade |
| Ardelyx, INC. | $49.87 | 2023 | Ibsrela |
| Csl Behring | $29.92 | 2023 | Kcentra |
| Vertex Pharmaceuticals Incorporated | $28.27 | 2025 | |
| Nalu Medical, INC. | $25.54 | 2025 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Maksumov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.